Your browser doesn't support javascript.
loading
Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.
Akaberi, Dario; Chinthakindi, Praveen K; Båhlström, Amanda; Palanisamy, Navaneethan; Sandström, Anja; Lundkvist, Åke; Lennerstrand, Johan.
Afiliación
  • Akaberi D; Clinical Microbiology, Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
  • Chinthakindi PK; Zoonosis Science Center, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Båhlström A; The Beijer Laboratory, Department of Medicinal Chemistry, Drug Design and Discovery, Uppsala University, Uppsala, Sweden.
  • Palanisamy N; The Beijer Laboratory, Department of Medicinal Chemistry, Drug Design and Discovery, Uppsala University, Uppsala, Sweden.
  • Sandström A; HBIGS, University of Heidelberg, Heidelberg, Germany.
  • Lundkvist Å; Institute of Biology II, University of Freiburg, Freiburg, Germany.
  • Lennerstrand J; The Beijer Laboratory, Department of Medicinal Chemistry, Drug Design and Discovery, Uppsala University, Uppsala, Sweden.
J Biomol Struct Dyn ; 38(18): 5526-5536, 2020 Nov.
Article en En | MEDLINE | ID: mdl-31880199

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Proteínas del Virus de la Inmunodeficiencia Humana / Virus Zika / Infección por el Virus Zika Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Biomol Struct Dyn Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Proteínas del Virus de la Inmunodeficiencia Humana / Virus Zika / Infección por el Virus Zika Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Biomol Struct Dyn Año: 2020 Tipo del documento: Article